Trial Condition(s):
Venous Thromboembolism
Dose-ranging study of once-daily regimen of BAY 59-7939 in the prevention of VTE in patients undergoing elective total Hip replacement (ODIXaHIP-OD)
Bayer Identifier:
11527
ClinicalTrials.gov Identifier:
EudraCT Number:
EU CT Number:
Not Available
Цель исследования
The purpose of this study is to assess different doses of a new drug (BAY 59-7939), taken as a tablet, are safe and can help prevent blood clots forming after a hip replacement operation. Patients undergoing hip replacement surgery are at risk of developing blood clots. To reduce this risk treatment to prevent clots forming is routinely given. The current treatments can include injections under the skin or other treatments that need frequent blood tests to monitor levels of drug in the body. Therefore there is a need for new drugs, which are easier to give and need less monitoring.
Критерии включения
- Male patients aged 18 years or above and postmenopausal female patients - Patients scheduled for elective primary total hip replacement (cemented or non-cemented prosthesis) - Patients written informed consent for participation after receiving detailed written and oral previous information to any study specific procedures
Критерии исключения
- Related to medical history: -- Any VTE prior to randomization -- Myocardial infarction (MI) or TIA or ischaemic stroke within the last 6 months prior to randomisation -- History of heparin-induced thrombocytopenia, allergy to heparins- Intracerebral or intraocular bleeding within the last 6 months prior to randomisation - History of gastrointestinal disease with gastrointestinal bleeding within the last 6 months prior to the study - History or presence of gastrointestinal disease which could result in an impaired absorption of the study drug (e.g. severe active inflammatory bowel disease, short gut syndrome) - Amputation of one legRelated to current symptoms or findings: -- Heart insufficiency NYHA class III-IV- Congenital or acquired haemorrhagic diathesis (PT INR/aPTT not within normal limits) including patients with acquired or congenital thrombopathy -- Thrombocytopenia (platelets < 100.000/µl)- Macroscopic haematuria- Allergy to contrast media- Severe hypertension (SBP > 200 mmHg, DBP > 100 mmHg)- Impaired liver function (transaminases > 2 x ULN) -- Impaired renal function (serum creatinine > 1.5 x ULN or creatinine clearance < 30 ml/min) -- Active malignant disease - Presence of active peptic ulcer or gastrointestinal disease with increased risk of gastrointestinal bleeding- Body weight < 45 kg -- Drug- or alcohol abuse- Related to current treatment- Patients who cannot stop therapy (in the opinion of the investigator/physician) with anticoagulants (e.g. phenprocoumon, warfarin-sodium, heparins and factor Xa inhibitors other than study medication) should be excluded from the study -- Fibrinolytic therapy- Therapy with acetylic salicylic acid or other platelet aggregation inhibitors (e.g. clopidogrel, dipyridamole and ticlopidine) should be stopped one week before enrolment. Patients not able to stop ASA therapy will be excluded -- All other drugs influencing coagulation, (exception: NSAIDs with half life < 17 hrs) will be not allowed during the study treatment period- Systemic and topical treatment with azole compounds (e.g. ketoconazole, fluconazole, itraconazole) and other strong CYP3A4-inhibitors eg HIV-protease inhibitors. Azole compounds and other strong CYP3A4-inhibitors eg HIV-protease should be stopped at least four days before enrolment - Therapy with another investigational product within 30 days prior start of study - Miscellaneous - Planned intermittent pneumatic compression during active treatment period - Planned epidural anaesthesia with indwelling epidural catheter (spinal or epidural anaesthesia without indwelling catheter are allowed) - If traumatic or repeated epidural and spinal puncture occur the patient should be excluded from study - Concomitant participation in another trial or study
Резюме исследования
Enrollment Goal
Trial Dates
Phase
Могу ли я получить плацебо?
Products
Accepts Healthy Volunteers
Где принять участие
| Местоположения | |
|---|---|
Местоположения Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria, 4010 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Ziekenhuis Oost-Limburg GENK, Belgium, 3600 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Städtische Kliniken Frankfurt am Main / Hoechst Frankfurt, Germany, 65929 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Kings College Hospital London, United Kingdom, SE5 9RS | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Donauspital im SMZ-Ost der Stadt Wien Wien, Austria, 1220 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Virga Jesse Ziekenhuis HASSELT, Belgium, 3500 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Kreiskrankenhaus Rheinfelden Rheinfelden, Germany, 79618 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Institut Montsouris - Paris PARIS CEDEX 14, France, 75877 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Ravenscourt Park Hospital London, United Kingdom, W6 0TN | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения IRCCS Ist Clinico Humanitas Rozzano, Italy, 20089 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения St. Maartenskliniek NIJMEGEN, Netherlands, 6522 JV | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Wojewodzki Szpital Specjalistyczny im. S. Wyszynskiego SPZOZ Lublin, Poland, 20-718 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Kungälvs Sjukhus Kungälv, Sweden, 442 83 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Clinique les Maussins-Nollet - Paris PARIS CEDEX 19, France, 75019 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения IRCCS Fondazione San Raffaele Milano, Italy, 20132 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Nordsjællands Hospital - Hørsholm Hørsholm, Denmark, DK-2970 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения PolyClinique de la providence - Poitiers POITIERS, France, 86000 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Rambam Medical Center Haifa, Israel, 31096 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения AUSL 1 Perugia - Umbria Gubbio, Italy, 06024 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Tergooiziekenhuizen Hilversum HILVERSUM, Netherlands, 1213 XZ | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Helse Blefjell Rjukan sykehus Rjukan, Norway, NO-3660 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Samodzielny Publiczny Szpital Kliniczny nr 4 Lublin, Poland, 20-090 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения SU/Östra Göteborg, Sweden, 416 85 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Regionshospitalet Silkeborg Silkeborg, Denmark, 8600 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Assaf Harofeh Medical Center Zerifin, Israel, 70300 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Notodden sykehus Notodden, Norway, NO-3675 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Allgem. öffentl. Krankenhaus Wiener Neustadt Wiener Neustadt, Austria, 2700 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения ZNA Middelheim ANTWERPEN, Belgium, 2020 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Klinikum Garmisch-Partenkirchen Garmisch-Partenkirchen, Germany, 82467 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Lovisenberg Diakonale sykehus Oslo, Norway, 0440 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Länssjukhuset Halmstad, Sweden, 301 85 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Imeldaziekenhuis - St-Elisabethkliniek BONHEIDEN, Belgium, 2820 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Sana Kliniken Sommerfeld, Germany, 16766 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Länssjukhuset Ryhov Jönköping, Sweden, 551 85 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Edith Wolfson Medical Center Holon, Israel, 58100 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения A.O. San Gerardo di Monza Monza, Italy, 20052 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Wojskowy Instytut Medyczny Warszawa, Poland, 00-909 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Rabin Medical Center, Campus Golda Petach Tikva, Israel, 49372 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Istituto Ortopedico G.Pini Milano, Italy, 20122 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Szpital Kliniczny nr 3 Gdansk, Poland, 80-742 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Rabin Medical Center - Beilinson Campus Petach Tikva, Israel, 49100 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Medizinische Einrichtungen der Heinrich-Heine-Universität Düsseldorf, Germany, 40225 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Asklepios Klinikum Melsungen Melsungen, Germany, 34212 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Herlev Hospital Herlev, Denmark, 2730 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Ciutat Sanitària i Universitaria de la Vall d'Hebrón Barcelona, Spain, 08035 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Spaarne Ziekenhuis HOOFDDORP, Netherlands, 2134 TM | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения SP Szpital Kliniczny AM w Bialymstoku Bialystok, Poland, 15-276 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения A.ö. Krankenhaus der Stadt Linz Linz, Austria, 4020 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Gentofte Hospital Hellerup, Denmark, 2900 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Hospital Universitari Germans Trias i Pujol Badalona, Spain, 08916 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Polyclinique de l'Atlantique - Saint Herblain SAINT HERBLAIN, France, 44819 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Sapir Medical Center, Meir General Hospital Kfar Saba, Israel, 44281 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения IRCCS Ist Ortopedico Rizzoli Bologna, Italy, 40136 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Wojewodzki Szpital Specjalistyczny im. Rydygiera Krakow, Poland, 31-826 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Klinikum Fürth Fürth, Germany, 90766 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Hospital Clínico Universitario San Carlos Madrid, Spain, 28040 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Medizinische Fakultät Carl Gustav Carus Dresden, Germany, 01307 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Orthopädische Universitätsklinik - Friedrichsheim Frankfurt, Germany, 60528 | Contact Us: E-mail: [email protected] Phone: Not Available |
Местоположения Klinikum der Philipps-Universität Marburg, Germany, 35043 | Contact Us: E-mail: [email protected] Phone: Not Available |
Проект исследования
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in patients undergoing Elective total Hip Replacement- ODIXaHIP-OD
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Prevention
Allocation:
Randomized
Blinding:
Double Blind
Assignment:
Parallel Assignment
Trial Arms:
6
Primary Outcome
- Composite Endpoint of Deep Vein Thrombosis (DVT), non-fatal Pulmonary Embolism (PE) and Death from all causesTimeframe: 6-10 days after surgery
Secondary Outcome
- Incidence of DVTs (total, proximal, distal)Timeframe: 6-10 days after surgery
- Incidence of symptomatic Venous Thrombo Embolisms (VTEs)Timeframe: 6-10 days after surgery
- Incidence of major VTE (ie, Proximal DVT, PE or VTE-related death)Timeframe: 6-10 days after surgery
- The composite endpoint that results from the primary endpoint by substituting VTE related death for all deathTimeframe: 40 дня/дней
- Incidence of symptomatic VTEs (total, PE, DVT) within 30 days after stop of treatment with the study drugTimeframe: 40 дня/дней
Дополнительная информация
Охраняется авторским правом © Bayer
При поддержке
